Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

84.75

+0.05 (0.06%)

At close: Aug 17, 2026, 4:00 PM EDT

84.83

+0.08 (0.09%)

After-hours: Aug 17, 2026, 6:07 PM EDT

Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,989	4,417	4,742	2,377	985	1,340
Market Cap Growth	217.21%	-6.84%	99.50%	141.36%	-26.50%	188.40%
Enterprise Value	7,830	3,374	3,932	1,874	620	1,151
Last Close Price	84.70	46.55	51.13	35.58	18.30	28.41

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	213.19	573.96	4563.69	592.26	207.88	1242.80
PB Ratio	7.52	4.45	3.58	4.41	3.11	4.04
P/TBV Ratio	7.54	4.45	3.58	4.41	3.11	4.04

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	185.71	438.42	3783.97	467.04	130.82	1067.39

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.04	0.05	0.04	0.10	0.01	0.01
Net Debt / Equity Ratio	-0.97	-0.99	-0.98	-0.94	-1.05	-0.99
Net Debt / EBITDA Ratio	2.13	1.91	3.88	2.29	1.99	3.09
Net Debt / FCF Ratio	2.73	2.55	5.57	2.93	2.84	3.70
Asset Turnover	0.03	0.01	0.00	0.01	0.01	0.00
Quick Ratio	15.24	12.09	22.69	12.92	12.17	20.96
Current Ratio	15.57	12.32	23.05	13.07	12.45	21.55
Return on Equity (ROE)	-42.45%	-40.17%	-32.02%	-50.16%	-50.57%	-42.98%
Return on Assets (ROA)	-26.28%	-25.22%	-20.46%	-28.18%	-29.84%	-25.19%
Return on Capital Employed (ROCE)	-44.20%	-49.60%	-24.60%	-37.60%	-51.70%	-32.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-5.58%	-10.53%	-6.29%	-9.03%	-16.65%	-8.04%
FCF Yield	-4.73%	-8.69%	-4.94%	-7.29%	-11.87%	-6.64%
Buyback Yield / Dilution	-11.25%	-16.43%	-39.11%	-11.71%	-35.24%	-26.24%

SEC Filings: 10-K · 10-Q